user avatar
CGH
@AGA_CGH
Clinical Gastroenterology and Hepatology (CGH) is the official clinical practice journal of the @AmerGastroAssn. Impact Factor: 12.0
Bethesda, MD
Joined March 2017
Posts
  • Pinned
    user avatar
    CGH has received a 2024 Impact Factor of 12.0! On behalf of Editor-in-Chief Charles Kahi, thank you to our editors, authors, reviewers, and readers for your continued support. ow.ly/j03050We50o #GITwitter #LiverTwitter @JosephHabibi_MD
  • user avatar
    Microscopic colitis can be detected with certainty by analyzing biopsies from the ascending and descending colon. ow.ly/jk9n50AWBz3
  • user avatar
    Study finds carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis. Check out the full article here: ow.ly/oWNm50PCBoQ
  • user avatar
    February Editor's Essential Reading examines rare, overlooked, and underappreciated causes of recurrent abdominal pain. Learn more at ow.ly/wXHa50MAqsU
  • user avatar
    CGH is excited to welcome its new social media editor: Joseph Sleiman, University of Pittsburgh Medical Center ➡️ @JosephHabibi_MD @AmerGastroAssn
  • user avatar
    AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review @AmerGastroAssn ow.ly/UknV50IZ9Ha
  • user avatar
    Image of the Month presents pembrolizumab-induced sclerosing cholangitis ow.ly/XAzJ50HEUW4
  • user avatar
    Great news! Clinical Gastroenterology and Hepatology, AGA’s clinically focused journal, reached a record-high 2020 Impact Factor of 11.382, pulling ahead as the field’s top exclusively clinically oriented journal!
  • user avatar
    Our July @AmerGastroAssn patient education section focuses on diabetic #gastroparesis ow.ly/a9i150Akx8v
  • user avatar
    New and updated analysis of financial burden of 38 common #digestive conditions by @SimonMathewsMD and colleagues ow.ly/oS3X50FTyej
  • user avatar
    Our March @AmerGastroAssn patient education section reviews #CRC screening options: ow.ly/XL9J50ywrqO
  • user avatar
    Image of the Month describes a retained foreign body in the distal esophagus: ow.ly/88Yj50CdoWH
  • user avatar
    We’re excited to announce the release of our supplement on Hepatic Encephalopathy! This is a collaboration with @JHospMedicine. Thanks to @JasmohanBajaj for chairing this program and to Salix Pharmaceuticals for their support ow.ly/w3he50KeR7A
  • user avatar
    Combining vedolizumab or ustekinumab with an immunomodulator is no more effective than monotherapy in induction or maintenance of remission in patients with IBD: ow.ly/K7A150EjWC2